Publication: First clinical implementation of Yttrium-90 Disc Brachytherapy after FDA clearance
Liberty Vision is pleased to announce the world’s first publication on LV Y-90 Disc brachytherapy! This new technology was initially employed to treat patients with iris, and iridociliary melanomas as well as ocular surface malignant squamous carcinoma. However,...
Pilot Production Begins
Liberty Vision CEO Contributes to New Book
Dr. Paul Finger, CEO of Liberty Vision, was a founding editor of a new open-access collaborative open-access surgical textbook, “Surgical Ophthalmic Oncology.” This book was written to help patients in countries with no eye cancer specialist.
